GoodRx Holdings (GDRX) Other Non-Current Liabilities (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Other Non-Current Liabilities data on file, last reported at $8.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 25.79% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $8.7 million (up 25.79% YoY), and the FY2025 full-year result was $8.7 million, up 29.4% from the prior year.
• Other Non-Current Liabilities eased to $8.7 million in Q1 2026, from $8.7 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $9.6 million in Q2 2023 to a low of $4.7 million in Q1 2022.
• A 5-year average of $7.7 million and a median of $7.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities dropped 25.09% in 2022 and jumped 70.04% in 2023, its largest moves.
• Tracing GDRX's Other Non-Current Liabilities over 5 years: stood at $7.6 million in 2022, then advanced by 8.2% to $8.2 million in 2023, then declined by 17.39% to $6.8 million in 2024, then increased by 29.4% to $8.7 million in 2025, then fell by 0.56% to $8.7 million in 2026.
• Business Quant data shows GDRX's Other Non-Current Liabilities at $8.7 million in Q1 2026, $8.7 million in Q4 2025, and $7.6 million in Q3 2025.